Shares of Cesca Therapeutics Inc (NASDAQ:KOOL) were down 9.1% on Wednesday . The stock traded as low as $0.49 and last traded at $0.50. Approximately 1,291,300 shares changed hands during trading, an increase of 206% from the average daily volume of 422,214 shares. The stock had previously closed at $0.55.
Several analysts have recently weighed in on KOOL shares. HC Wainwright initiated coverage on shares of Cesca Therapeutics in a research report on Wednesday, May 23rd. They set a “buy” rating and a $1.50 price objective for the company. ValuEngine upgraded shares of Cesca Therapeutics from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd.
The stock has a market cap of $10.40 million, a P/E ratio of -0.48 and a beta of -1.06. The company has a current ratio of 1.61, a quick ratio of 0.79 and a debt-to-equity ratio of 0.23.
Cesca Therapeutics (NASDAQ:KOOL) last released its quarterly earnings results on Thursday, March 22nd. The biotechnology company reported $0.01 EPS for the quarter. Cesca Therapeutics had a negative net margin of 56.21% and a negative return on equity of 20.31%. The firm had revenue of $2.94 million during the quarter. analysts expect that Cesca Therapeutics Inc will post -0.55 earnings per share for the current year.
About Cesca Therapeutics
Cesca Therapeutics Inc develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products.
Receive News & Ratings for Cesca Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.